DeZeeuw, A.K.; Bassetti, M.F.; Carchman, E.H.; Heise, C.P.; Hayden, D.; Lawson, E.H.; Sanger, C.B.; King, R.; LoConte, N.K.; Lubner, S.J.;
et al. Carboplatin and Paclitaxel Chemoradiation for Localized Anal Cancer in Patients Not Eligible for Mitomycin and 5-Fluorouracil. Cancers 2024, 16, 3062.
https://doi.org/10.3390/cancers16173062
AMA Style
DeZeeuw AK, Bassetti MF, Carchman EH, Heise CP, Hayden D, Lawson EH, Sanger CB, King R, LoConte NK, Lubner SJ,
et al. Carboplatin and Paclitaxel Chemoradiation for Localized Anal Cancer in Patients Not Eligible for Mitomycin and 5-Fluorouracil. Cancers. 2024; 16(17):3062.
https://doi.org/10.3390/cancers16173062
Chicago/Turabian Style
DeZeeuw, Alyssa K., Michael F. Bassetti, Evie H. Carchman, Charles P. Heise, Dana Hayden, Elise H. Lawson, Cristina B. Sanger, Ray King, Noelle K. LoConte, Sam J. Lubner,
and et al. 2024. "Carboplatin and Paclitaxel Chemoradiation for Localized Anal Cancer in Patients Not Eligible for Mitomycin and 5-Fluorouracil" Cancers 16, no. 17: 3062.
https://doi.org/10.3390/cancers16173062
APA Style
DeZeeuw, A. K., Bassetti, M. F., Carchman, E. H., Heise, C. P., Hayden, D., Lawson, E. H., Sanger, C. B., King, R., LoConte, N. K., Lubner, S. J., Kratz, J. D., & Deming, D. A.
(2024). Carboplatin and Paclitaxel Chemoradiation for Localized Anal Cancer in Patients Not Eligible for Mitomycin and 5-Fluorouracil. Cancers, 16(17), 3062.
https://doi.org/10.3390/cancers16173062
